Policy Prism AI

Federal

Waivers.

21 CFR § 312.10

Source text

9 segments

21 CFR § 312.10

21 CFR § 312.10

Waivers.

(a)

A sponsor may request FDA to waive applicable requirement under this part. A waiver request may be submitted either in an IND or in an information amendment to an IND. In an emergency, a request may be made by telephone or other rapid communication means. A waiver request is required to contain at least one of the following:

(1)

An explanation why the sponsor's compliance with the requirement is unnecessary or cannot be achieved;

(2)

A description of an alternative submission or course of action that satisfies the purpose of the requirement; or

(3)

Other information justifying a waiver.

(b)

FDA may grant a waiver if it finds that the sponsor's noncompliance would not pose a significant and unreasonable risk to human subjects of the investigation and that one of the following is met:

(1)

The sponsor's compliance with the requirement is unnecessary for the agency to evaluate the application, or compliance cannot be achieved;

(2)

The sponsor's proposed alternative satisfies the requirement; or

(3)

The applicant's submission otherwise justifies a waiver.